Parthenon Therapeutics
PrivateLast Round
Series A
Nov 3, 2021
Total Funding Raised
$65M
Company Overview
Parthenon Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in November 2021.
Parthenon Therapeutics is a biotechnology company that invents a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parthenon Therapeutics Comparables
Compare Parthenon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoGenesis | 83% | |
| Apmonia Therapeutics | 78% | |
| Alentis Therapeutics | 74% |
For institutional investors. Book with your work email.
Parthenon Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Parthenon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Creacion Ventures | Series A |
| Taiho Ventures | Series A |
| Northpond Ventures | Series A |
| Tekla Capital Management | Series A |
| Breakout Ventures | Series A |
| Alexandria Venture Investments | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 160% MoM, reaching 2K.
- Nov 9, 2024
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Parthenon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Parthenon Therapeutics's valuation, stock price, and market status.
Is Parthenon Therapeutics a public or private company?
Parthenon Therapeutics is a private company.
What is the current stock price of Parthenon Therapeutics?
Parthenon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Parthenon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Parthenon Therapeutics worth (valuation)?
Valuation information for Parthenon Therapeutics is not publicly available.
Can I buy Parthenon Therapeutics stock?
Parthenon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Parthenon Therapeutics's last funding round?
Parthenon Therapeutics's most recent funding round was Series A on November 3, 2021.
Who are the main investors in Parthenon Therapeutics?
Key investors in Parthenon Therapeutics include Taiho Ventures, Northpond Ventures, Pfizer Ventures.
Will Parthenon Therapeutics IPO soon?
No public IPO plans have been announced for Parthenon Therapeutics.
How can I track Parthenon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Parthenon Therapeutics's shares on secondary markets.